OSCR — Oscar Health, Inc. stock price, charts and financials

QT90Oscar Health, Inc.

Oscar Health, Inc. (NYSE: OSCR) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
30.38
-0.36-1.17%
OverviewShort InterestFilings
OSCRQT90Oscar Health, Inc.·NYSE
30.38-1.17%
Earnings
Down 1.2% — Earnings due 2026-08-06 — pre-report positioning.
Medium confidence
TA
Loading chart...
Signal & projected range
Analyst consensus risingHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
MOH-1.75%$191.36ALHC-7.14%$13.52CLOV-1.39%$4.27CNC+0.49%$64.07HUM-3.30%$362.16CI-2.84%$274.05ELV-1.25%$378.00CVS-0.90%$104.42
Snapshot
Index-P/E-EPS (ttm)-0.54Insider Own17.67%Shs Outstand259.27MPerf Week8.47%
Market Cap7.97BForward P/E19.73EPS next Y1.56Insider Trans-6.24%Shs Float249.19MPerf Month-4.47%
Enterprise Value1.60BPEG-EPS next Q-Inst Own-Short Float7.86%Perf Quarter66.25%
Income-39.00MP/S0.60EPS this Y304.33%Inst Trans-Short Ratio2.72Perf Half Y114.22%
Sales13.30BP/B4.78EPS next Y41.17%ROA-0.42%Short Interest19.58MPerf YTD113.92%
Book/sh6.43P/C1.17EPS next 5Y28.73%ROE-3.27%52W High32.71 -7.13%Perf Year118.79%
Cash/sh26.23P/FCF2.89EPS past 3/5Y-ROIC0.49%52W Low10.56 187.56%Perf 3Y293.09%
Dividend Est.-EV/EBITDA84.27Sales past 3/5Y41.55% 81.75%Gross Margin17.39%Volatility6.39% 5.46%Perf 5Y63.77%
Dividend TTM-EV/Sales0.12EPS Y/Y TTM-664.26%Oper. Margin0.08%ATR (14)1.69Perf 10Y-
Dividend Ex-Date-Quick Ratio1.09Sales Y/Y TTM44.93%Profit Margin-0.30%RSI (14)55.22Recom2.91
Dividend Gr. 3/5Y-Current Ratio1.09EPS Q/Q125.00%SMA201.55%Beta2.35Target Price26.17
Payout0.00%Debt/Eq0.44Sales Q/Q52.56%SMA509.40%Rel Volume0.49Prev Close30.74
Employees2,305LT Debt/Eq0.44EarningsAug 06SMA20061.99%Avg Volume6.93MPrice30.38
IPO DateMar 03, 2021Option/ShortYes / YesEPS/Sales Surpr.86.81% -6.36%Net Debt/EBITDA-227.46Volume3,381,913Change-1.17%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-28-26ReiteratedPiper SandlerOverweight$26 → $36
Jun-15-26ReiteratedRaymond James$18 → $30
Jun-10-26UpgradeBarclaysEqual Weight → Overweight$30 → $35
Jun-04-26ReiteratedWells FargoUnderweight$14 → $20
May-26-26ReiteratedBarclaysEqual Weight$21 → $30
May-07-26ReiteratedUBSNeutral$15 → $20
May-07-26ReiteratedBarclaysEqual Weight$18 → $21
Apr-20-26UpgradeJefferiesUnderperform → Hold$16
Feb-12-26ReiteratedRaymond James$20 → $18
Feb-11-26ReiteratedUBSNeutral$17 → $15
Latest News
Aug-04-26
Aug-04-2601:27PM
Oscar Health (OSCR) Price Target Increased by 10.12% to 24.05Fintel
Jul-30-26
Jul-30-2611:06AM
Oscar Health, Inc. (OSCR) Reports Next Week: Wall Street Expects Earnings Growthzacks.com
Jul-29-26
Jul-29-2607:01PM
Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Todayzacks.com
10:35AM
Oscar Health, Inc. (OSCR) Recently Broke Out Above the 20-Day Moving Averagezacks.com
Jul-28-26
Jul-28-2607:51PM
Is Oscar Health Inc (OSCR) Overvalued After 10.8% Rally? GF Value Says Overvaluedgurufocus.com
08:00AM
Oscar Health, Inc. to Host 2026 Investor Daybusinesswire.com
Jul-24-26
Jul-24-2611:24PM
Oscar Health: Scale Is Finally Showing Up On The Bottom-Lineseekingalpha.com
Jul-22-26
Jul-22-2607:01PM
Oscar Health, Inc. (OSCR) Registers a Bigger Fall Than the Market: Important Facts to Notezacks.com
12:40PM
Oscar Health: Strong Numbers Forced Re-Rating, Now Pay Attention To Continuous Executionseekingalpha.com
Jul-17-26
Jul-17-2610:01AM
Oscar Health, Inc. (OSCR) Is a Trending Stock: Facts to Know Before Betting on Itzacks.com
Jul-16-26
Jul-16-2609:56AM
Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investorszacks.com
Jul-15-26
Jul-15-2607:01PM
Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: What You Should Knowzacks.com
02:46PM
5 Multiline Insurers to Buy Amid Inflation, Softening Pricingzacks.com
10:22AM
Elevance Health's Small Outlook Boost Disappoints, Stock SinksBenzinga
Jul-09-26
Jul-09-2607:01PM
Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Knowzacks.com
Company

Oscar Health, Inc. operates as a health insurance provider across the United States. Its offerings include various health plans such as those for individuals and families, small businesses, and Medicare Advantage options. The company also features "+Oscar," a proprietary technology platform designed to facilitate engagement between healthcare providers, payers, and their members or patients. Additionally, Oscar Health provides reinsurance solutions. Originally established as Mulberry Health Inc., the firm officially changed its name to Oscar Health, Inc. in January 2021. It was founded in 2012 and maintains its main office in New York, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue13,30211,7019,1785,8634,1261,921590554
Cost of Goods Sold Incl. D&A10,98910,0197,3334,6420000
Gross Profit2,3131,6821,8451,2214,1261,921590554
Selling, General and Administrative Excl. Other1,2172,050001,419265167111
Research and Development
00000000
Other Operating Expense1,085291,7881,4563,3172,227828702
Operating Income11-39657-236-610-571-406-259
Interest Expense1718242523540
Unusual Expense
————————
Non-Operating Income (Expense)-20-230-723540
Net Income Before Taxes-27-43733-267-610-571-406-259
Income Taxes13673-1112
Consolidated Net Income-39-44325-271-606-573-407-261
Net Income From Continuing Operations-38-44326-271-610-571-407-261
Net Income-39-44325-271-606-573-407-261
EPS (Recurring)-0.38-1.690.11-1.22-2.85-3.19-1.70-8.93
EPS (Basic, Before Extraordinaries)-0.38-1.690.11-1.22-2.85-3.19-1.70-8.93
EPS (Diluted)-0.54-1.690.10-1.22-2.85-3.19-1.70-1.09
EBITDA19-39189-212-572-551-391-252
Other After Tax Adjustments
————————
Stock Option Compensation Expense
————————
Price To Earnings Ratio——140.44—————
Price To Sales Ratio0.680.320.350.350.130.73——
Gross Margin17.3914.3720.1020.83100.00100.00100.00100.00
Operating Margin0.08-3.380.62-4.03-14.78-29.72-68.81-46.75
Net Margin-0.29-3.790.27-4.62-14.69-29.83-68.98-47.11
Shares Outstanding29826224022221217923929
Market Capitalization9,0533,7653,2262,0315221,405——
Operating Lease Expense
————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$35.38$28.45$21.52$14.58$7.65● Close Price0.00M25.46M50.92M76.37M101.83MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Schlosser MarioDirectorJul 01 '26Sale31.2447,5001,484,0140Jul 06
Bertolini Mark TChief Executive OfficerJun 30 '26Sale28.48624,24417,781,3837,751,570Jul 01
Bertolini Mark TChief Executive OfficerJun 29 '26Sale29.26614,75217,985,9388,375,814Jul 01
Bertolini Mark TChief Executive OfficerJun 26 '26Sale29.28591,16817,310,7618,990,566Jun 29
Bertolini Mark TChief Executive OfficerJun 25 '26Sale28.61615,14217,601,3179,581,734Jun 29
Schlosser MarioDirectorJun 23 '26Option Exercise0.00660,00002,092,293Jun 25
Schlosser MarioDirectorJun 23 '26Sale29.37993,70529,183,6540Jun 25
Blackley Richard ScottChief Financial OfficerJun 02 '26Sale21.9431,683695,1621,074,977Jun 04
Baltrus VictoriaChief Accounting OfficerJun 02 '26Sale21.941,52333,416214,589Jun 04
Schlosser MarioDirectorJun 02 '26Sale21.9434,120748,633480,866Jun 04
McAnaney AdamChief Legal OfficerJun 02 '26Sale21.949,859216,318218,096Jun 04
Liang JanetPresident, Oscar InsuranceJun 02 '26Sale21.9412,475273,717259,057Jun 04
Blackley Richard ScottChief Financial OfficerMay 18 '26Sale25.03110,0002,753,3001,106,660May 20
Blackley Richard ScottChief Financial OfficerMay 14 '26Sale23.16100,0002,316,0311,216,660May 18
Bertolini Mark TChief Executive OfficerApr 06 '26Buy11.921,000,00011,920,00010,196,876Apr 07
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.